Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 21;25(14):7962.
doi: 10.3390/ijms25147962.

Vasorelaxant and Hypotensive Effects of Galla chinensis in Rats

Affiliations

Vasorelaxant and Hypotensive Effects of Galla chinensis in Rats

Sujin Shin et al. Int J Mol Sci. .

Abstract

Previous studies have revealed the medicinal and therapeutic effects of Galla chinensis. However, no studies have focused on the antihypertensive effects of G. chinensis. Therefore, we aimed to determine the vasorelaxant and hypotensive effects of G. chinensis 50% ethanolic extract (GCE). To evaluate the vascular relaxing effect of GCE, experiments were conducted using aortic segments dissected from Sprague Dawley rats. GCE showed a vasorelaxant effect via the nitric oxide/cyclic guanosine 3',5'-monophosphate pathway, inhibiting Ca2+ channels, and activating K+ channels. The hypotensive effects of GCE were evaluated in spontaneously hypertensive rats (SHRs). The SHRs were randomly divided into a control group and orally administered GCE group (100 or 300 mg/kg). The systolic and diastolic blood pressure decreased significantly by -19.47 ± 4.58% and -31.14 ± 7.66% in the GCE 100 mg/kg group, and -21.64 ± 2.40% and -31.91 ± 5.75% in the GCE 300 mg/kg group at 4 h after administration. Considering its vasorelaxant and hypotensive effects, our results indicate that GCE may be a valuable solution for the control of hypertension. However, further studies on the long-term administration and toxicity of GCE are required.

Keywords: Chinese gallnut; Galla chinensis; NO/cGMP pathway; blood pressure; cardiovascular diseases; endothelium; hypertension; hypotensive effect; spontaneously hypertensive rat; vasorelaxant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
High-performance liquid chromatography (HPLC) analysis of (A) Galla chinensis 50% ethanol extract (GCE) and (B) gallic acid. AU, Absorbance units.
Figure 2
Figure 2
Galla chinensis 50% ethanol extract (GCE)-induced concentration-dependent relaxation of the endothelium-intact [Endo(+)] or -removed [Endo(−)] aorta. To confirm the integrity of endothelium, aortas pre-constricted by phenylephrine (PE) were administered with acetylcholine (ACh). (A) Relaxation response to cumulative doses of GCE and (B) representative tracing. Data are shown as the means ± standard error of the mean (SEM) (n = 4–5). * p < 0.05, *** p < 0.001 vs. control.
Figure 3
Figure 3
Galla chinensis 50% ethanol extract (GCE)-induced concentration-dependent relaxation of aortic rings pre-incubated with NG-nitro-L-arginine methyl ester (L-NAME), indomethacin, 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) or methylene blue (MB). Rings were constricted by phenylephrine (PE) before the GCE-induced relaxation. (A) Relaxation response to cumulative doses of GCE and (B) representative tracing. Data are shown as the means ± SEM (n = 5). *** p < 0.001 vs. control.
Figure 4
Figure 4
Inhibitory effect of Galla chinensis 50% ethanol extract (GCE) on vasoconstriction of endothelium-intact aortic rings induced by calcium chloride (CaCl2). Rings were pre-treated with phenylephrine (PE) before the vasoconstriction by CaCl2. (A) Contraction response to cumulative doses of GCE and (B) representative traces. Data are shown as the means ± SEM (n = 4–5). *** p < 0.001 vs. control.
Figure 5
Figure 5
Galla chinensis 50% ethanol extract (GCE)-induced concentration-dependent relaxation of the aortic rings pre-treated with barium chloride (BaCl2), 4-aminopyridine (4-AP), or tetraethylammonium (TEA). Rings were constricted with phenylephrine (PE) before the GCE-induced relaxation. (A) Relaxation response to cumulative doses of GCE and (B) representative tracing. Data are shown as the means ± SEM (n = 4–6). *** p < 0.001 vs. control.
Figure 6
Figure 6
Effects of Galla chinensis 50% ethanol extract (GCE) on aortas constricted by angiotensin II. (A) Contraction response to cumulative doses of GCE and (B) representative traces. Data are shown as the means ± SEM (n = 5).
Figure 7
Figure 7
Hypotensive effect of Galla chinensis 50% ethanol extract (GCE). Blood pressure of spontaneously hypertensive rats was measured after GCE (100 and 300 mg/kg) administration. (A) Systolic blood pressure (SBP), (B) diastolic blood pressure (DBP), (C) percent changes in SBP, (D) percent changes in DBP. Data are shown as the means ± SEM (n = 6–7). * p < 0.05, ** p < 0.01 vs. control.

Similar articles

Cited by

References

    1. Saheera S., Krishnamurthy P. Cardiovascular Changes Associated with Hypertensive Heart Disease and Aging. Cell Transplant. 2020;29:0963689720920830. doi: 10.1177/0963689720920830. - DOI - PMC - PubMed
    1. Dunbar S.B., Khavjou O.A., Bakas T., Hunt G., Kirch R.A., Leib A.R., Morrison R.S., Poehler D.C., Roger V.L., Whitsel L.P., et al. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035 A Policy Statement from the American Heart Association. Circulation. 2018;137:E558–E577. doi: 10.1161/CIR.0000000000000570. - DOI - PubMed
    1. Wang C., Yuan Y., Zheng M., Pan A., Wang M., Zhao M., Li Y., Yao S., Chen S., Wu S., et al. Association of Age of Onset of Hypertension with Cardiovascular Diseases and Mortality. J. Am. Coll. Cardiol. 2020;75:2921–2930. doi: 10.1016/j.jacc.2020.04.038. - DOI - PubMed
    1. NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55. doi: 10.1016/S0140-6736(16)31919-5. - DOI - PMC - PubMed
    1. Poulter N.R., Borghi C., Parati G., Pathak A., Toli D., Williams B., Schmieder R.E. Medication adherence in hypertension. J. Hypertens. 2020;38:579–587. doi: 10.1097/HJH.0000000000002294. - DOI - PubMed

LinkOut - more resources